News

Img 5093

CorVent Receives FDA Approval for Respond Critical Care Ventilator

CorVent Medical announced that it has received FDA 510(k) clearance for its Respond critical care ventilator system.

Designed to be a cost-effective solution, Respond provides simple, safe, and smart ventilation to help expand access to quality care for healthcare systems, providers, and patients.

The lightweight and user-friendly ventilator integrates traditional mechanical ventilation with durable, long-lasting components. It eliminates the need for service and maintenance contracts, while offering a full range of features, including non-proprietary circuits and accessories, as well as low-pressure oxygen for long-term affordability.

“Simple and highly reliable, the Respond ventilator is a front-line ventilator in a value-focused and resource-constrained world,” said Dr. Patrick Troy, chief medical officer, CorVent Medical. “Its robust design maximizes total cost of ownership, delivering significant savings for hospital systems, emergency stockpiles, long-term acute care hospitals (LTACHs) and skilled nursing facilities (SNFs).”

CorVent engineered Respond to serve the needs of all patients, from pediatric to adult. It includes all standard breathing modes, with both invasive and non-invasive ventilation capabilities. The system also features a patient-prioritized alarm system, hot-swappable batteries, and the ability to integrate with EMR systems for seamless communication.

“We are extremely pleased that the U.S. FDA has cleared our Respond critical care ventilator,” said President and CEO Richard S. Walsh. ”Achieving FDA 510(k) clearance for the RESPOND ventilator is a testament to our commitment to advancing medical technology and addressing the critical needs of patients and healthcare professionals. This accomplishment not only reinforces our dedication to innovation but also marks a significant step in revitalizing U.S. manufacturing in the medical device sector.”

“This marks a significant milestone as it is the first U.S.-manufactured ventilator to receive FDA clearance in over 20 years. We plan on expanding our product line with additional transformational products that deliver value-based solutions for our customers.”


©
Corvent Medical Inc.

Post a comment

Your email address will not be published. Required fields are marked *

Recent News

Relevance Ventures Leads Multimillion-Dollar Series B Financing for Aqua Medical to Advance Minimally Invasive Type 2 Diabetes Treatment

The Growth of the Medical Industry Amid Tariff Pressures and the Push to Reshore Manufacturing to the United States

Vent Creativity℠ Obtains FDA-Clearance for AI-Powered Digital-Twin Knee Arthroplasty Planning Tool, Hermes.

Johnson & Johnson MedTech Announces Approval of MONARCH™ QUEST for Enhanced Robotic-Assisted Bronchoscopy

Globus Medical obtains FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System

Successful completion of the inaugural shoulder arthroplasty surgeries utilizing Stryker’s Blueprint® Mixed Reality Guidance System occurred at Mayo Clinic in Minnesota and St. Joseph’s Health Care in London, Canada.

Medical Device Technologies Market is projected to increase from USD 4.20 Billion in 2022 to USD 16.32 Billion by 2030, reflecting a robust Compound Annual Growth Rate (CAGR) of 18.50% over the forecast period

Hodess Cleanroom Construction expands its cleanroom services capabilities with the acquisitions of Protocol Management Services and Clean Rooms West

Medtronic Will Invest Up to $75 Million And begin Co-Promotion For CathWorks’ FFRangio System In The U.S. Europe and Japan

Tornier Shoulder Arthroplasty Portfolio Introduced by Stryker, With New Tornier Perform Humeral System Launched in Europe